ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals

February 11, 2011

In Brief: Organ systems Coordinating Center Decision Still Delayed; Branch Merged With DCPC Centers Branch

June 29, 1984

NCI’s SBIR Awards Move Up In Quality; Congress considers Making It Permanent; FASEB Object

September 19, 1986

ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.

May 18, 2001

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

November 3, 1995

ACCC Enthusiastically Support New Effort Or Clinical Research

April 3, 1981